In a recent development, AstraZeneca has acknowledged the potential for rare but serious blood clot side effects associated with their COVID-19 vaccine. This revelation came to light in court documents filed as part of an undisclosed legal case. AstraZeneca collaborated with the University of Oxford to develop the vaccine and is currently involved in legal proceedings initiated by victims and their families. One particular case includes Jamie Scott, a father of two, who took legal action after experiencing a blood clot that rendered him unable to work. Scott claims that following his vaccination in April 2021, he developed a “blood clot and a bleed on his brain,” resulting in a lasting brain injury. Credit: The Telegraph The specific side effect mentioned is Thrombosis with Thrombocytopenia Syndrome (TTS), which involves unusual blood clotting combined with low platelet counts. While this is a very rare occurrence, it’s crucial for individuals to be aware of the potential risks. AstraZeneca, marketed as Covishield in India, has also expressed its sympathy for those affected. “Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority,…
The post AstraZeneca Confirms Rare Blood Clot Side Effect Associated with COVID-19 Vaccine first appeared on Egyptian Streets.
Source: egyptianstreets
